Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000598
Filing Date
2025-03-31
Accepted
2025-03-31 17:23:24
Documents
95
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nwbo-20241231x10k.htm   iXBRL 10-K 3347392
2 EX-4.1 nwbo-20241231xex4d1.htm EX-4.1 17845
3 EX-10.5 nwbo-20241231xex10d5.htm EX-10.5 83649
4 EX-10.8 nwbo-20241231xex10d8.htm EX-10.8 69866
5 EX-10.9 nwbo-20241231xex10d9.htm EX-10.9 52409
6 EX-10.10 nwbo-20241231xex10d10.htm EX-10.10 69794
7 EX-10.11 nwbo-20241231xex10d11.htm EX-10.11 290732
8 EX-19.1 nwbo-20241231xex19d1.htm EX-19.1 2202
9 EX-21.1 nwbo-20241231xex21d1.htm EX-21.1 5799
10 EX-23.1 nwbo-20241231xex23d1.htm EX-23.1 2610
11 EX-31.1 nwbo-20241231xex31d1.htm EX-31.1 12878
12 EX-32.1 nwbo-20241231xex32d1.htm EX-32.1 6558
13 GRAPHIC nwbo-20241231x10k007.jpg GRAPHIC 41695
14 GRAPHIC nwbo-20241231x10k008.jpg GRAPHIC 55954
  Complete submission text file 0001410578-25-000598.txt   15758278

Data Files

Seq Description Document Type Size
15 EX-101.SCH nwbo-20241231.xsd EX-101.SCH 100972
16 EX-101.CAL nwbo-20241231_cal.xml EX-101.CAL 73937
17 EX-101.DEF nwbo-20241231_def.xml EX-101.DEF 443957
18 EX-101.LAB nwbo-20241231_lab.xml EX-101.LAB 712178
19 EX-101.PRE nwbo-20241231_pre.xml EX-101.PRE 629232
98 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20241231x10k_htm.xml XML 3083502
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 25795126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)